Form 4: Ingevity Corp Director J. Kevin Willis Acquires Shares Through Deferred Stock Units
SEC Form 4
Director J. Kevin Willis acquired 580 shares of Ingevity Corp common stock through vested deferred stock units (DSUs) at a price of $38.85 per share.
Summary
- On April 1, 2025, J. Kevin Willis, a director of Ingevity Corp, acquired 580 shares of common stock.
- The acquisition was through vested deferred stock units (DSUs) granted in lieu of quarterly director fees.
- The price per share was $38.85.
- Following the transaction, Willis directly owns 2,966 shares of Ingevity Corp common stock.
- These DSUs will settle into shares upon termination of board service according to the company's compensation plan.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard transaction related to director compensation, indicating alignment of interests between the director and shareholders.
Positives
- Director's acquisition of shares demonstrates confidence in the company.
- The acquisition is part of a deferred compensation plan, aligning director's interests with long-term company performance.
Future Outlook
The deferred stock units will settle into an equal number of shares of the Company's Common Stock upon the reporting person's termination of board service pursuant to the Company's Non-Employee Director Deferred Compensation Plan and 2016 Omnibus Incentive Plan, as amended.
Industry Context
Directors receiving stock-based compensation is a common practice to align their interests with shareholders and incentivize long-term value creation. This filing reflects standard executive compensation practices.
Comparison to Industry Standards
- Stock-based compensation for directors is a common practice across publicly traded companies.
- Companies like Eastman Chemical Company (EMN) and WestRock Company (WRK) also utilize deferred compensation plans for their directors.
- The amount of deferred stock units granted is generally aligned with industry benchmarks for director compensation.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of transaction: Acquisition of shares through vested deferred stock units. |
| 04/02/2025 | Date of signature for the Form 4 filing. |
Keywords
Ingevity Corp, Director, Stock Acquisition, Deferred Stock Units, NGVT, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.